|
|
|
| home > white papers > Personalised Medicine - Pharma and Dx Firms Share Wider Horizons - DiagnostikNet-BB |
|
|
 WHITE PAPERS |
|
DiagnostikNet-BB
|
|
Personalised Medicine - Pharma and Dx Firms Share Wider Horizons
|
|
Personalised medicine might be a popular catch-phrase at the moment, but the term often causes confusion, as there is still no uniform definition for it. The expression can include areas as diverse as the measurement of individual risk, early detection using biomarker testing, stratification of patients suffering from a disease and predictions about its course.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Anaqua and PatSnap Team Up to Deliver an End-to-End Pharma IP Management Solution
BOSTON, December 7, 2022 – Anaqua, the leading provider of
innovation and intellectual property management technology, today
announced it is partnering with innovation intelligence platform
PatSnap. The collaboration will deliver an enhanced IP management
solution to provide Anaqua’s pharmaceutical industry clients with a more
detailed and informed view of the market and competitive landscape for
key use cases. The combined Anaqua AQX® Pharma and PatSnap
Synapse solutions will help AQX Pharma clients further enhance
competitiveness, keep up with the fast-paced requirements of the current
market, eliminate duplicated work across functions, as well as identify
and realize new areas of investment.
More info >> |
|
 |
White Papers |
 |
|
Clinical Trial Disclosure Management: Build vs. Buy
TrialScope
Because software development is our core competency, TrialScope continues to make a significant investment in our technology. We employ agile methodologies to ensure that we can maintain a continuing level of responsiveness as disclosure requirements evolve across registries and regions.
More info >> |
|
|
|
